Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimization and Refinement of Technique in In-Office Sinus Dilation 2 (ORIOS 2)

NCT01107379 is registered in ClinicalTrials.gov with Integra LifeSciences Corporation as lead sponsor.

NCT NCT01107379
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01107379 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimization and Refinement of Technique in In-Office Sinus Dilation 2 (ORIOS 2)
Lead sponsor
Integra LifeSciences Corporation
Phase
Observational
Overall status
Completed
Start date
April 30, 2010
Completion date
July 31, 2012
Enrollment
203 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

sinusitis